Literature DB >> 3499836

Prognostic factors and life expectancy of patients with acquired immunodeficiency syndrome and Pneumocystis carinii pneumonia.

M Brenner1, F P Ognibene, E E Lack, J T Simmons, A F Suffredini, H C Lane, A S Fauci, J E Parrillo, J H Shelhamer, H Masur.   

Abstract

To assess determinants of prognosis for 43 patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii pneumonia, objective clinical and histopathologic characteristics were analyzed for acute and long-term prognostic significance. Severe abnormalities on initial chest radiographs and alveolar-arterial oxygen differences (AaPO2) greater than 30 mm Hg were associated with higher mortality during the period of treatment for the acute episode (p less than 0.05). Decreased long-term survival after the diagnosis of Pneumocystis pneumonia correlated with the severity of interstitial edema (a component of diffuse alveolar damage) on initial transbronchial biopsy and elevation of AaPO2 at the time of diagnosis (Cox proportional hazards analysis, p less than 0.05). The persistence of Pneumocystis cysts after 3 wk of therapy was associated with significantly decreased long-term survival (p less than 0.05) when follow-up biopsy was performed in 27 of the patients. Patients with a diagnosis of Pneumocystis pneumonia before July 1985 had more advanced disease at the time of diagnosis and a worse prognosis than did those in whom the diagnosis was made after July 1985 (p less than 0.05). This study demonstrates that important prognostic information can be derived from information obtained at initial presentation and follow-up bronchoscopic evaluation in patients with AIDS and Pneumocystis carinii pneumonia, and suggests that early detection and initiation of therapy may improve chances for survival.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3499836     DOI: 10.1164/ajrccm/136.5.1199

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS.

Authors:  M J Gill; R Read
Journal:  Can J Infect Dis       Date:  1991

2.  Concomitant sarcoidosis and HIV infection.

Authors:  K S Gowda; I Mayers; S D Shafran
Journal:  CMAJ       Date:  1990-01-15       Impact factor: 8.262

Review 3.  AIDS and the lung. 7. Treatment of lung disease in patients with the acquired immune deficiency syndrome.

Authors:  D M Mitchell; M A Johnson
Journal:  Thorax       Date:  1990-03       Impact factor: 9.139

Review 4.  Aids and the lung. 6-- Management of respiratory failure in patients with the acquired immune deficiency syndrome and Pneumocystis carinii pneumonia.

Authors:  R F Miller; D M Mitchell
Journal:  Thorax       Date:  1990-02       Impact factor: 9.139

5.  Health insurance and utilization in Pneumocystis carinii pneumonia.

Authors:  S Loue; D J Slymen; H Morgenstern; C Whalen
Journal:  J Gen Intern Med       Date:  1995-08       Impact factor: 5.128

6.  Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

Authors:  A Antinori; G Maiuro; F Pallavicini; F Valente; G Ventura; G Marasca; R Murri; E Pizzigallo; G Camilli; E Tamburrini
Journal:  Eur J Epidemiol       Date:  1993-03       Impact factor: 8.082

Review 7.  Optimal management strategies for HIV-infected patients who present with cough or dyspnea: a cost-effective analysis.

Authors:  K A Freedberg; A N Tosteson; D J Cotton; L Goldman
Journal:  J Gen Intern Med       Date:  1992 May-Jun       Impact factor: 5.128

8.  Arterial desaturation in HIV positive patients undergoing sputum induction.

Authors:  R F Miller; J Buckland; S J Semple
Journal:  Thorax       Date:  1991-06       Impact factor: 9.139

9.  Predicting mortality from HIV-associated Pneumocystis pneumonia at illness presentation: an observational cohort study.

Authors:  M W Fei; E J Kim; C A Sant; L G Jarlsberg; J L Davis; A Swartzman; L Huang
Journal:  Thorax       Date:  2009-10-12       Impact factor: 9.139

10.  Predicting in-hospital outcome in HIV-associated Pneumocystis carinii pneumonia.

Authors:  T Bauer; S Ewig; E Hasper; J K Rockstroh; B Lüderitz
Journal:  Infection       Date:  1995 Sep-Oct       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.